Stéphane Epelbaum

10.4k total citations · 1 hit paper
67 papers, 2.2k citations indexed

About

Stéphane Epelbaum is a scholar working on Psychiatry and Mental health, Physiology and Cognitive Neuroscience. According to data from OpenAlex, Stéphane Epelbaum has authored 67 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Psychiatry and Mental health, 33 papers in Physiology and 12 papers in Cognitive Neuroscience. Recurrent topics in Stéphane Epelbaum's work include Dementia and Cognitive Impairment Research (39 papers), Alzheimer's disease research and treatments (31 papers) and Functional Brain Connectivity Studies (7 papers). Stéphane Epelbaum is often cited by papers focused on Dementia and Cognitive Impairment Research (39 papers), Alzheimer's disease research and treatments (31 papers) and Functional Brain Connectivity Studies (7 papers). Stéphane Epelbaum collaborates with scholars based in France, United States and Italy. Stéphane Epelbaum's co-authors include Bruno Dubois, Kaj Blennow, Marc Teichmann, Harald Hampel, Nicolas Villain, Stéphanie Bombois, Christopher C. Rowe, Gil D. Rabinovici, Stefano F. Cappa and Howard Feldman and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Brain.

In The Last Decade

Stéphane Epelbaum

62 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group

2021 598 citations Bruno Dubois, Stéphanie Bombois et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stéphane Epelbaum France	24	903	818	646	347	321	67	2.2k
Panagiotis Alexopoulos Germany	29	1.2k 1.4×	945 1.2×	522 0.8×	339 1.0×	369 1.1×	110	2.6k
Alexandre Bejanin France	23	1.1k 1.3×	1.1k 1.4×	857 1.3×	380 1.1×	287 0.9×	58	2.4k
Giovanni B. Frisoni Switzerland	22	1.0k 1.1×	1.1k 1.3×	407 0.6×	369 1.1×	406 1.3×	129	2.3k
Meredith N. Braskie United States	28	676 0.7×	768 0.9×	638 1.0×	265 0.8×	328 1.0×	79	2.0k
Enrica Cavedo Italy	20	681 0.8×	692 0.8×	497 0.8×	339 1.0×	236 0.7×	35	1.7k
Daniele Altomare Switzerland	18	725 0.8×	694 0.8×	376 0.6×	315 0.9×	234 0.7×	52	1.7k
Erin M. Jonaitis United States	28	1.4k 1.5×	1.3k 1.6×	495 0.8×	421 1.2×	387 1.2×	111	2.9k
Robert Laforce Canada	26	1.1k 1.2×	717 0.9×	1.1k 1.8×	376 1.1×	276 0.9×	117	2.6k
Jee Hyang Jeong South Korea	25	1.1k 1.2×	775 0.9×	391 0.6×	370 1.1×	238 0.7×	163	2.1k
Nicolas Villain France	19	1.2k 1.3×	1.3k 1.6×	880 1.4×	390 1.1×	320 1.0×	68	2.7k

Countries citing papers authored by Stéphane Epelbaum

Since Specialization

Citations

This map shows the geographic impact of Stéphane Epelbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Epelbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Epelbaum more than expected).

Fields of papers citing papers by Stéphane Epelbaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Epelbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Epelbaum. The network helps show where Stéphane Epelbaum may publish in the future.

Co-authorship network of co-authors of Stéphane Epelbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Epelbaum. A scholar is included among the top collaborators of Stéphane Epelbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Epelbaum. Stéphane Epelbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schöll, Michael, Agathe Vrillon, Takeshi Ikeuchi, et al.. (2025). Cutting through the noise: A narrative review of Alzheimer's disease plasma biomarkers for routine clinical use. The Journal of Prevention of Alzheimer s Disease. 12(4). 100056–100056. 9 indexed citations

Dumurgier, Julien, Claire Paquet, Jacques Hugon, et al.. (2025). MemScreen: A smartphone application for detection of mild cognitive impairment: A validation study. The Journal of Prevention of Alzheimer s Disease. 12(3). 100077–100077.

Perneczky, Robert, James A. Hendrix, Stéphane Epelbaum, et al.. (2025). How can Alzheimer's disease blood‐based biomarkers reach clinical practice?. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 17(4). e70207–e70207. 1 indexed citations

Koval, Igor, Colin Birkenbihl, Vincent Bouteloup, et al.. (2023). Forecasting individual progression trajectories in Alzheimer’s disease. Nature Communications. 14(1). 761–761. 25 indexed citations

Daly, Timothy & Stéphane Epelbaum. (2022). The Accelerated Approval of Aducanumab Invites a Rethink of the Current Model of Drug Development for Alzheimer's Disease. AJOB Neuroscience. 14(3). 332–335. 5 indexed citations

Epelbaum, Stéphane, Ninon Burgos, Michael Canney, et al.. (2022). Pilot study of repeated blood-brain barrier disruption in patients with mild Alzheimer’s disease with an implantable ultrasound device. Alzheimer s Research & Therapy. 14(1). 40–40. 53 indexed citations

Houot, Marion, Raffaella Migliaccio, Stéphanie Bombois, et al.. (2022). Subtle postoperative cognitive disorder in preclinical Alzheimer's disease. Experimental Gerontology. 161. 111715–111715.

Daly, Timothy, et al.. (2021). A Proposal to Make Biomedical Research into Alzheimer’s Disease More Democratic Following an International Survey with Researchers. Journal of Alzheimer s Disease Reports. 5(1). 637–645. 6 indexed citations

Epelbaum, Stéphane, Emmanuel Roze, Sophie Ferrieux, et al.. (2021). A Reliable and Rapid Language Tool for the Diagnosis, Classification, and Follow-Up of Primary Progressive Aphasia Variants. Frontiers in Neurology. 11. 571657–571657. 15 indexed citations

10.

Daly, Timothy, et al.. (2020). The ethics of innovation for Alzheimer’s disease: the risk of overstating evidence for metabolic enhancement protocols. Metamedicine. 41(5-6). 223–237. 10 indexed citations

11.

Wen, Junhao, Jorge Samper‐Gonzàlez, Simona Bottani, et al.. (2020). Reproducible Evaluation of Diffusion MRI Features for Automatic Classification of Patients with Alzheimer’s Disease. Neuroinformatics. 19(1). 57–78. 17 indexed citations

12.

Ansart, Manon, Stéphane Epelbaum, Alexandre Bône, et al.. (2020). Predicting the progression of mild cognitive impairment using machine learning: A systematic, quantitative and critical review. Medical Image Analysis. 67. 101848–101848. 58 indexed citations

13.

Gaubert, Sinead, Federico Raimondo, Marion Houot, et al.. (2019). EEG evidence of compensatory mechanisms in preclinical Alzheimer’s disease. Brain. 142(7). 2096–2112. 148 indexed citations

14.

Grabli, David, Danielle Seilhean, Carole Azuar, et al.. (2018). First European case of Creutzfeldt-Jakob disease with a PRNP G114V mutation. Cortex. 117. 407–413. 3 indexed citations

15.

Cacciamani, Federica, Caroline Tandetnik, Geoffroy Gagliardi, et al.. (2017). Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease.. PubMed. 59(2). 753–762. 45 indexed citations

16.

Lista, Simone, Nicola Toschi, Filippo Baldacci, et al.. (2017). Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease. Neurochemistry International. 108. 355–360. 44 indexed citations

17.

Dubois, Bruno, Stéphane Epelbaum, Francesca Di Stefano, et al.. (2013). Alzheimer disease: From biomarkers to diagnosis. Revue Neurologique. 169(10). 744–751. 20 indexed citations

18.

Epelbaum, Stéphane, Philippe Pinel, Raphaël Gaillard, et al.. (2008). Pure alexia as a disconnection syndrome: New diffusion imaging evidence for an old concept. Cortex. 44(8). 962–974. 223 indexed citations

19.

Epelbaum, Stéphane, et al.. (2006). Two cases of papillary glioneuronal tumours. British Journal of Neurosurgery. 20(2). 90–93. 24 indexed citations

20.

Epelbaum, Stéphane, et al.. (1992). [Value of the intestinal permeability test with lactulose-mannitol for screening and monitoring of celiac disease in children].. PubMed. 49(1). 33–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact